Literature DB >> 12409165

Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia.

Piet Oosthuizen1, Robin A Emsley, Mimi C Roberts, Jadri Turner, Linda Keyter, Natasha Keyter, Martijn Torreman.   

Abstract

There is uncertainty regarding the prognostic value of depressive symptoms in schizophrenia, having previously been associated with both favourable and poor outcome. This study investigated the relationship between baseline depressive symptoms and treatment outcome at 6, 12 and 24 weeks in 80 subjects with first-episode schizophrenia or schizophreniform disorder in terms of PANSS total and subscale score changes. No significant association was found between baseline PANSS depression factor scores and PANSS total and subscore changes. However, a significant inverse correlation between baseline depression scores and negative scores at 6, 12 and 24 weeks was found (p=0.044, 0.023 and 0.012, respectively). Multiple regression analysis indicated that this finding could not be explained on the basis of age, gender or duration of untreated psychosis. These findings support previous work suggesting that high baseline depressive scores predict favourable outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409165     DOI: 10.1016/s0920-9964(01)00375-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

Review 1.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

2.  The relationships between depression and remission in first-episode psychosis.

Authors:  Piet Oosthuizen; Robin Emsley; Dana Niehaus; Liezl Koen; Bonga Chiliza
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

3.  Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Authors:  Diego Novick; Josep Maria Haro; David Suarez; Martin Lambert; Jean-Pierre Lépine; Dieter Naber
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.530

4.  Association between financial strain, social network and five-year recovery from first episode psychosis.

Authors:  Maria Mattsson; Alain Topor; Johan Cullberg; Yvonne Forsell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-05       Impact factor: 4.328

5.  The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis.

Authors:  Ibrahim Turkoz; Dong-Jing Fu; Cynthia A Bossie; Larry Alphs
Journal:  Innov Clin Neurosci       Date:  2015 Nov-Dec

Review 6.  A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia.

Authors:  Costa Vakalopoulos
Journal:  Ment Illn       Date:  2010-05-06

Review 7.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

Authors:  Maren Carbon; Christoph U Correll
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

8.  Suicidal behaviour after first-episode psychosis: results from a 1-year longitudinal study in Portugal.

Authors:  Ricardo Coentre; Alexandra Fonseca; Tiago Mendes; Ana Rebelo; Elisabete Fernandes; Pedro Levy; Carlos Góis; Maria Luísa Figueira
Journal:  Ann Gen Psychiatry       Date:  2021-07-06       Impact factor: 3.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.